ATS 2018 International Conference - Mobile

Higher Baseline Blood Eosinophil Levels Are Associated with Greater Improvement in Quality of Life with Reslizumab Treatment [Board No. P886]

Location: Board no. P886

Session Type: Thematic Poster Session

Sunday

May

20

11:15 AM

1:00 PM

Speaker(s)/Author(s)

Mirna McDonald

Ms
Teva Pharmaceuticals

Margaret C. Garin

MD
Teva Pharmaceuticals

Jorge F. Maspero

MD
Fundación CIDEA

View Abstract

Higher Baseline Blood Eosinophil Levels Are Associated with Greater Improvement in Quality of Life with Reslizumab Treatment

Parent Sessions

A34 - ASTHMA CLINICAL STUDIES I
05-20-2018 9:15 AM - 4:15 PM